MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Mouse Model for the Study of Energy Expenditure, Weight Gain, and Diabetes Susceptibility

University of Nebraska Medical Center / UNeMed Corporation
Manipulation of the knockout gene appears to be a promising target to not only treat obesity and diabetes, but to develop therapeutics to decrease energy expenditure for under-nourished populations.

Full description

The incidence of human obesity and diabetes is rising and has become a major concern for public health. The relationship between obesity, diabetes and energy expenditure is unclear, and ongoing research is aimed at determining both environmentally and physiologically relevant factors. Researchers at the University of Nebraska Medical Center have developed a mouse model that will provide insight into these relationships. Their results indicate that compared to control mice, these knockout mice expend less energy while engaging in the same amount of activity, eat less while becoming overweight, and show pre-diabetic symptoms. Manipulation of the knockout gene appears to be a promising target to not only treat obesity and diabetes, but to develop therapeutics to decrease energy expenditure for under-nourished populations.

Patent information

Application Pending

(TID - 83)

Type of business relationship sought

UNeMed Corporation offers a variety of licensing options and collaborative development opportunities with the University of Nebraska Medical Center.

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
Need competitive intelligence information
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us